002826 易明医药
已收盘 04-27 15:00:00
资讯
新帖
简况
图解易明医药年报：第四季度单季净利润同比增长163.24%
证券之星 · 41分钟前
图解易明医药年报：第四季度单季净利润同比增长163.24%
易明医药：截至2026年4月20日，本公司股东数为16,557户
证券之星 · 04-22
易明医药：截至2026年4月20日，本公司股东数为16,557户
易明医药：截至2026年4月10日股东数为16,084户
证券之星 · 04-14
易明医药：截至2026年4月10日股东数为16,084户
股市必读：易明医药(002826)股东户数1.6万户，较上期增加0.7%
证券之星 · 04-07
股市必读：易明医药(002826)股东户数1.6万户，较上期增加0.7%
易明医药：截至2026年3月31日，本公司股东数为15,976户
证券之星 · 04-02
易明医药：截至2026年3月31日，本公司股东数为15,976户
股市必读：易明医药(002826)股东户数1.59万户，较上期减少6.82%
证券之星 · 03-25
股市必读：易明医药(002826)股东户数1.59万户，较上期减少6.82%
股市必读：易明医药（002826）3月23日收盘跌7.47%，主力净流出1539.37万元
证券之星 · 03-24
股市必读：易明医药（002826）3月23日收盘跌7.47%，主力净流出1539.37万元
易明医药（002826）发布公司2026年限制性股票激励计划首次授予公告，3月11日股价下跌2.37%
证券之星 · 03-11
易明医药（002826）发布公司2026年限制性股票激励计划首次授予公告，3月11日股价下跌2.37%
易明医药（002826）披露2026年限制性股票激励计划获临时股东大会审议通过，3月10日股价下跌3.33%
证券之星 · 03-10
易明医药（002826）披露2026年限制性股票激励计划获临时股东大会审议通过，3月10日股价下跌3.33%
易明医药（002826）披露2026年限制性股票激励计划首次授予激励对象名单审核及公示情况说明，3月3日股价下跌0.62%
证券之星 · 03-03
易明医药（002826）披露2026年限制性股票激励计划首次授予激励对象名单审核及公示情况说明，3月3日股价下跌0.62%
易明医药(002826)2月27日股东户数1.72万户，较上期增加0.2%
证券之星 · 03-02
易明医药(002826)2月27日股东户数1.72万户，较上期增加0.2%
易明医药(002826)2月10日股东户数1.77万户，较上期增加0.18%
证券之星 · 02-12
易明医药(002826)2月10日股东户数1.77万户，较上期增加0.18%
股市必读：易明医药（002826）2月4日董秘有最新回复
证券之星 · 02-05
股市必读：易明医药（002826）2月4日董秘有最新回复
易明医药：公司无原研药产品
证券之星 · 02-04
易明医药：公司无原研药产品
易明医药：姚劲波先生作为公司的实际控制人
证券之星 · 02-04
易明医药：姚劲波先生作为公司的实际控制人
异动快报：易明医药（002826）2月3日9点57分触及涨停板
证券之星 · 02-03
异动快报：易明医药（002826）2月3日9点57分触及涨停板
易明医药最新公告：2025年净利同比预增61.12%—122.08%
证券之星 · 01-29
易明医药最新公告：2025年净利同比预增61.12%—122.08%
易明医药(002826)1月20日股东户数1.84万户，较上期减少1.48%
中金财经 · 01-22
易明医药(002826)1月20日股东户数1.84万户，较上期减少1.48%
易明医药：截至2026年1月9日股东数为18,668户
证券之星 · 01-14
易明医药：截至2026年1月9日股东数为18,668户
股市必读：易明医药(002826)股东户数1.81万户，较上期增加0.25%
证券之星 · 01-07
股市必读：易明医药(002826)股东户数1.81万户，较上期增加0.25%
加载更多
公司概况
公司名称：
西藏易明西雅医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2016-12-09
主营业务：
西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是化学药、中成药。
发行价格：
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":19.76,"timestamp":1777273383000,"preClose":20.29,"halted":0,"volume":9057300,"delay":0,"changeRate":-0.0261,"floatShares":183000000,"shares":191000000,"eps":0.4504,"marketStatus":"已收盘","change":-0.53,"latestTime":"04-27 15:00:00","open":20.29,"high":20.33,"low":19.17,"amount":177000000,"amplitude":0.0572,"askPrice":19.76,"askSize":26,"bidPrice":19.75,"bidSize":47,"shortable":0,"etf":0,"ttmEps":0.4504,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":5,"adr":0,"adjPreClose":20.29,"symbolType":"stock","openAndCloseTimeList":[[1777253400000,1777260600000],[1777266000000,1777273200000]],"highLimit":22.32,"lowLimit":18.26,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.82,"roa":"--","peRate":43.872114,"roe":"10.54%","epsLYR":0.25,"committee":0.325581,"marketValue":3768000000,"turnoverRate":0.0495,"status":1,"floatMarketCap":3616000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2630631996","title":"图解易明医药年报：第四季度单季净利润同比增长163.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630631996","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630631996?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:26","pubTimestamp":1777310770,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药2025年年报显示，当年度公司主营收入6.36亿元，同比下降2.39%；归母净利润9258.07万元，同比上升101.57%；扣非净利润4899.0万元，同比上升165.58%；其中2025年第四季度，公司单季度主营收入1.47亿元，同比上升5.93%；单季度归母净利润1081.75万元，同比上升163.24%；单季度扣非净利润904.27万元，同比上升328.92%；负债率19.81%，投资收益349.67万元，财务费用-28.38万元，毛利率82.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629095598","title":"易明医药：截至2026年4月20日，本公司股东数为16,557户","url":"https://stock-news.laohu8.com/highlight/detail?id=2629095598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629095598?lang=zh_cn&edition=full","pubTime":"2026-04-22 11:30","pubTimestamp":1776828637,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问4月20日的股东人数是多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年4月20日，本公司股东数为16,557户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200025502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627167434","title":"易明医药：截至2026年4月10日股东数为16,084户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627167434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627167434?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:36","pubTimestamp":1776155767,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月10日公司股东人数是多少？谢谢！易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年4月10日，本公司股东数为16,084户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400026272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625609362","title":"股市必读：易明医药(002826)股东户数1.6万户，较上期增加0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625609362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625609362?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:42","pubTimestamp":1775504532,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，易明医药报收于20.0元，下跌3.01%，换手率2.45%，成交量4.27万手，成交额8630.78万元。交易信息汇总资金流向4月3日主力资金净流出351.29万元，占总成交额4.07%；游资资金净流入217.61万元，占总成交额2.52%；散户资金净流入133.68万元，占总成交额1.55%。股本股东变化股东户数变动近日易明医药披露，截至2026年3月31日公司股东户数为1.6万户，较3月20日增加111.0户，增幅为0.7%。户均持股数量由上期的1.2万股减少至1.19万股，户均持股市值为23.81万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624575372","title":"易明医药：截至2026年3月31日，本公司股东数为15,976户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624575372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624575372?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:00","pubTimestamp":1775113257,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘:您好！ 麻烦您告知公司截止3月31日的股东人数，谢谢！易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年3月31日，本公司股东数为15,976户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200019101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622097060","title":"股市必读：易明医药(002826)股东户数1.59万户，较上期减少6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622097060","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622097060?lang=zh_cn&edition=full","pubTime":"2026-03-25 02:43","pubTimestamp":1774377791,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘，易明医药报收于19.21元，上涨6.25%，换手率4.62%，成交量8.06万手，成交额1.5亿元。交易信息汇总资金流向3月24日主力资金净流入224.2万元；游资资金净流出915.21万元；散户资金净流入691.01万元。股本股东变化股东户数变动近日易明医药披露，截至2026年3月20日公司股东户数为1.59万户，较3月10日减少1161.0户，减幅为6.82%。户均持股数量由上期的1.12万股增加至1.2万股，户均持股市值为23.48万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500003933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621650085","title":"股市必读：易明医药（002826）3月23日收盘跌7.47%，主力净流出1539.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621650085","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621650085?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:58","pubTimestamp":1774288692,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，易明医药报收于18.08元，下跌7.47%，换手率4.82%，成交量8.41万手，成交额1.56亿元。当日关注点来自交易信息汇总：易明医药股价连续3日下跌，累计跌幅达18.41%，主力资金前10个交易日累计净流出超5151万元。来自交易信息汇总：3月23日易明医药收盘报18.08元，下跌7.47%，当日成交额为841.04万元。来自资金流向：3月23日主力资金净流出1539.37万元，而游资与散户资金分别净流入1314.14万元和225.22万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618492542","title":"易明医药（002826）发布公司2026年限制性股票激励计划首次授予公告，3月11日股价下跌2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618492542","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618492542?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:37","pubTimestamp":1773239836,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，易明医药报收于20.99元，较前一交易日下跌2.37%，最新总市值为40.02亿元。该股当日开盘21.73元，最高21.8元，最低20.81元，成交额达2亿元，换手率为5.45%。近日，易明医药披露《关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告》。本次激励计划拟授予总量为340.38万股，其中首次授予占比82.26%，预留17.74%。限售期为12个月，分两期各解除限售50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618959610","title":"易明医药（002826）披露2026年限制性股票激励计划获临时股东大会审议通过，3月10日股价下跌3.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618959610","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618959610?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:15","pubTimestamp":1773152121,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，易明医药报收于21.5元，较前一交易日下跌3.33%，最新总市值为41亿元。该股当日开盘22.43元，最高22.55元，最低21.0元，成交额达3.06亿元，换手率为8.15%。近日，西藏易明西雅医药科技股份有限公司发布《2026年第一次临时股东会决议公告》。关联股东对相关议案回避表决。会议召集、召开程序合法合规，表决结果有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332166","title":"易明医药（002826）披露2026年限制性股票激励计划首次授予激励对象名单审核及公示情况说明，3月3日股价下跌0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332166","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616332166?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:59","pubTimestamp":1772549952,"startTime":"0","endTime":"0","summary":"近日，西藏易明西雅医药科技股份有限公司披露《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的审核意见及公示情况说明》。公告显示，公司于2026年2月10日召开董事会及薪酬与考核委员会会议，审议通过《2026年限制性股票激励计划（草案）》；并于2026年2月12日至2月21日在内部企业微信群公示了首次授予激励对象的姓名和职务，公示期间未收到异议。激励对象主体资格合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300044801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616387136","title":"易明医药(002826)2月27日股东户数1.72万户，较上期增加0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616387136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616387136?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:31","pubTimestamp":1772443863,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年2月27日公司股东户数为1.72万户，较2月13日增加35.0户，增幅为0.2%。户均持股数量由上期的1.11万股减少至1.11万股，户均持股市值为23.82万元。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至2月27日，化学制药行业平均股东户数为3.42万户。根据统计，易明医药2026年2月13日至2026年2月27日，主力资金净流入157.09万元，游资资金净流入2909.08万元，散户资金净流出3066.18万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610946050","title":"易明医药(002826)2月10日股东户数1.77万户，较上期增加0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946050","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946050?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:32","pubTimestamp":1770888772,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年2月10日公司股东户数为1.77万户，较1月30日增加31.0户，增幅为0.18%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至2月10日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月30日至2026年2月10日，易明医药区间涨幅为10.87%，在此期间股东户数增加31.0户，增幅为0.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200028520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609539451","title":"股市必读：易明医药（002826）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609539451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609539451?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:50","pubTimestamp":1770227423,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，易明医药报收于21.24元，上涨1.24%，换手率10.64%，成交量18.55万手，成交额3.91亿元。董秘最新回复投资者： 最近股价回暖是否存在借壳预期？截至目前，公司未接到控股股东的相关指示，如有相关事项，公司将严格按照相关法律法规及时履行信息披露义务。请注意投资风险，感谢关注。交易信息汇总资金流向2月4日主力资金净流出550.76万元；游资资金净流出1747.68万元；散户资金净流入2298.44万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608821023","title":"易明医药：公司无原研药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2608821023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608821023?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:57","pubTimestamp":1770166635,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司有什么样原研药产品呢，会加强在原研药的创新力度吗易明医药回复：尊敬的投资者，您好。公司无原研药产品。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400007581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608438212","title":"易明医药：姚劲波先生作为公司的实际控制人","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438212","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608438212?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:55","pubTimestamp":1770166510,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问姚劲波先生参与公司管理吗易明医药回复：尊敬的投资者，您好。姚劲波先生作为公司的实际控制人，依照相关法规行使权利和履行义务，感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400007569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608171928","title":"异动快报：易明医药（002826）2月3日9点57分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2608171928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608171928?lang=zh_cn&edition=full","pubTime":"2026-02-03 10:01","pubTimestamp":1770084064,"startTime":"0","endTime":"0","summary":"证券之星2月3日盘中消息，9点57分易明医药触及涨停板。其所属行业化学制药目前上涨。该股为西藏概念，医药，中药概念热股，当日西藏概念概念上涨0.8%，医药概念上涨0.44%，中药概念上涨0.24%。2月2日的资金流向数据方面，主力资金净流入352.65万元，占总成交额2.82%，游资资金净流入1244.17万元，占总成交额9.96%，散户资金净流出1596.83万元，占总成交额12.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300010674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607072707","title":"易明医药最新公告：2025年净利同比预增61.12%—122.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607072707","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607072707?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:41","pubTimestamp":1769679676,"startTime":"0","endTime":"0","summary":"易明医药(002826.SZ)发布业绩预告，预计2025年净利润7400万元—1.02亿元，同比增长61.12%—122.08%。报告期内，公司紧随行业发展方向及政策导向，集中资源大力发展自产产品，不断提升自产产品价值与市场占有率，实现了核心自有产品米格列醇片的销量增长，带动整体利润提升，为公司的长期稳定发展奠定基础。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900030098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605446418","title":"易明医药(002826)1月20日股东户数1.84万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605446418","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605446418?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:42","pubTimestamp":1769074947,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年1月20日公司股东户数为1.84万户，较1月9日减少276.0户，减幅为1.48%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至1月20日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月9日至2026年1月20日，易明医药区间涨幅为5.05%，在此期间股东户数减少276.0户，减幅为1.48%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/22/20260122320308.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/22/20260122320308.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260122/31964287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0056","BK0033","002826","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603548666","title":"易明医药：截至2026年1月9日股东数为18,668户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603548666","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603548666?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:51","pubTimestamp":1768351865,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至1月10日的股东人数是多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2026年1月9日，本公司股东数为18,668户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400006687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601481810","title":"股市必读：易明医药(002826)股东户数1.81万户，较上期增加0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601481810","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601481810?lang=zh_cn&edition=full","pubTime":"2026-01-07 04:03","pubTimestamp":1767729795,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，易明医药报收于18.42元，下跌0.05%，换手率2.02%，成交量3.52万手，成交额6524.05万元。交易信息汇总资金流向1月6日主力资金净流出182.16万元；游资资金净流入369.74万元；散户资金净流出187.58万元。股本股东变化股东户数变动近日易明医药披露，截至2025年12月31日公司股东户数为1.81万户，较12月19日增加45.0户，增幅为0.25%。户均持股数量由上期的1.06万股减少至1.05万股，户均持股市值为19.35万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777313217797,"stockEarnings":[{"period":"1week","weight":-0.0657},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0324},{"period":"6month","weight":-0.0347},{"period":"1year","weight":0.8807},{"period":"ytd","weight":0.0751}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16557人(较上一季度增加2.94%)","perCapita":"11051股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":" 西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是化学药、中成药。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}